LIANYOTCPharmaceutical PreparationsFiscal year ends December 31
LianBio
Financials through Q3 FY2023, quarter ended Sep 30, 2023Last filing: 10-Q on Nov 13, 2023
$0.06+0.01 (+15.10%)
Close on Oct 19, 2026
- Market cap
- $6.29M
- P/E (TTM)
- –
- Dividend yield
- –
LianBio statistics
Financials through Dec 31, 2022, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Income (trailing twelve months)
| Measure | LianBio | Industry median |
|---|---|---|
| Operating Income | -$125.35M | -$21.40M |
| Pretax Income | -$110.62M | -$14.34M |
| Net Income | -$110.29M | -$22.46M |
| EBITDA | -$125.35M | -$16.91M |
| EPS (Diluted) | -$1.02 | -$0.83 |
Returns
| Measure | LianBio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -36.0% | -53.2% |
| Return on Assets (ROA) | -29.6% | -40.9% |
| Return on Capital Employed (ROCE) | -42.3% | -38.1% |
Balance sheet
| Measure | LianBio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $302.40M | $61.43M |
| Net Cash (Debt) | $302.40M | $15.35M |
| Net Cash Per Share | $2.80 | $0.66 |
| Equity (Book Value) | $259.87M | $49.09M |
| Book Value Per Share | $2.40 | $1.37 |
| Tangible Book Value | $259.87M | $23.52M |
| Working Capital | $289.16M | $76.81M |
Financial position
| Measure | LianBio | Industry median |
|---|---|---|
| Current Ratio | 13.24 | 3.34 |
| Quick Ratio | 12.81 | 2.44 |
Cash flow (trailing twelve months)
| Measure | LianBio | Industry median |
|---|---|---|
| Operating Cash Flow | -$99.19M | -$12.35M |
| Capital Expenditures | -$1.85M | -$1.08M |
| Free Cash Flow | -$101.03M | -$20.22M |
| FCF Per Share | -$0.93 | -$0.42 |
Efficiency
| Measure | LianBio | Industry median |
|---|---|---|
| Profits Per Employee | -$676.63K | -$703.34K |
| Employee Count | 163 | 74 |
Shares
| Measure | LianBio | Industry median |
|---|---|---|
| Shares Outstanding | 108,063,000 | 58,127,000 |
| Shares Change (YoY) | 213.8% | 10.9% |
| Float | 108,063,000 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
| Shares Held by Institutions | 0.01% | 59.4% |
Taxes
| Measure | LianBio | Industry median |
|---|---|---|
| Income Tax | -$333.00K | $79.87K |
Scores
| Measure | LianBio | Industry median |
|---|---|---|
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from LianBio's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.